Picard Medical, Inc.
ASE: PMILive Quote
About Picard Medical, Inc.
Healthcare
Medical Devices
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
📊 Fundamental Analysis
Picard Medical, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 20.7% revenue growth, which is well above average for the Healthcare sector.
At a current price of $0.94, PMI currently trades near the bottom of its 52-week range (0%), indicating potential value or weakness (Range: $0.92 - $13.68).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
Key Financials
Market Cap
$15.55M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
--
52W High
$13.68
52W Low
$0.92
Avg Volume
777K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App